Su Ni

3.3k total citations
25 papers, 809 citations indexed

About

Su Ni is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Su Ni has authored 25 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Rheumatology and 7 papers in Cancer Research. Recurrent topics in Su Ni's work include Osteoarthritis Treatment and Mechanisms (8 papers), Bone Tissue Engineering Materials (6 papers) and Inflammatory mediators and NSAID effects (5 papers). Su Ni is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Bone Tissue Engineering Materials (6 papers) and Inflammatory mediators and NSAID effects (5 papers). Su Ni collaborates with scholars based in China, United States and United Kingdom. Su Ni's co-authors include Chao Zhuang, Kaisong Miao, Nanwei Xu, Yuji Wang, Chenkai Li, Dong Li, Xianju Zhou, André J. van Wijnen, Zhicheng Yang and Ruiping Liu and has published in prestigious journals such as Scientific Reports, Gene and Journal of Cellular Physiology.

In The Last Decade

Su Ni

25 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Ni China 17 376 217 142 107 89 25 809
Zhanwang Xu China 13 429 1.1× 131 0.6× 116 0.8× 67 0.6× 68 0.8× 44 780
Xiangyu Chu China 16 305 0.8× 137 0.6× 105 0.7× 75 0.7× 130 1.5× 32 783
Yongjian Zhao China 19 472 1.3× 146 0.7× 79 0.6× 88 0.8× 68 0.8× 54 897
Hongli Jiao United States 19 535 1.4× 169 0.8× 126 0.9× 177 1.7× 113 1.3× 32 1.2k
Wenxiang Cheng China 19 453 1.2× 222 1.0× 111 0.8× 108 1.0× 171 1.9× 54 1.2k
Deming Xiao China 11 345 0.9× 115 0.5× 174 1.2× 75 0.7× 106 1.2× 23 711
Huaqiang Tao China 13 481 1.3× 148 0.7× 115 0.8× 117 1.1× 154 1.7× 35 875
Liaojun Sun China 16 341 0.9× 200 0.9× 96 0.7× 69 0.6× 38 0.4× 26 686
Yiming Zhong China 9 446 1.2× 460 2.1× 138 1.0× 110 1.0× 61 0.7× 13 1.0k

Countries citing papers authored by Su Ni

Since Specialization
Citations

This map shows the geographic impact of Su Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Ni more than expected).

Fields of papers citing papers by Su Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Ni. The network helps show where Su Ni may publish in the future.

Co-authorship network of co-authors of Su Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Su Ni. A scholar is included among the top collaborators of Su Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Ni. Su Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhuangzhuang, Xu Chen, Jie Chen, et al.. (2025). Acetyl zingerone inhibits chondrocyte pyroptosis and alleviates osteoarthritis progression by promoting mitophagy through the PINK1/parkin signaling pathway. International Immunopharmacology. 161. 115055–115055. 2 indexed citations
2.
Ni, Su, et al.. (2024). Strontium-Modified porous attapulgite composite hydrogel scaffold with advanced angiogenic and osteogenic potential for bone defect repair. Composites Part A Applied Science and Manufacturing. 187. 108492–108492. 5 indexed citations
3.
Yuan, Hang, Yi Ning, Dong Li, et al.. (2024). PPARγ regulates osteoarthritis chondrocytes apoptosis through caspase-3 dependent mitochondrial pathway. Scientific Reports. 14(1). 11237–11237. 9 indexed citations
4.
Xu, Chao, et al.. (2024). Sulfasalazine promotes ferroptosis through AKT-ERK1/2 and P53-SLC7A11 in rheumatoid arthritis. Inflammopharmacology. 32(2). 1277–1294. 18 indexed citations
5.
Ni, Su, Yi Ning, Hang Yuan, et al.. (2023). Angelica sinensis polysaccharide improves mitochondrial metabolism of osteoarthritis chondrocytes through PPARγ/SOD2/ROS pathways. Phytotherapy Research. 37(11). 5394–5406. 23 indexed citations
6.
7.
Dai, Ting, Chun Liu, Su Ni, et al.. (2023). Fabrication of a three-dimensional printed gelatin/sodium alginate/nano-attapulgite composite polymer scaffold loaded with leonurine hydrochloride and its effects on osteogenesis and vascularization. International Journal of Biological Macromolecules. 249. 126028–126028. 21 indexed citations
8.
Huang, Yizhi & Su Ni. (2023). Aggregatibacter Actinomycetemcomitans With Periodontitis and Rheumatoid Arthritis. International Dental Journal. 74(1). 58–65. 9 indexed citations
9.
Qi, Hong, Yang Liu, Lu Wu, et al.. (2022). Mg-HA-C/C Composites Promote Osteogenic Differentiation and Repair Bone Defects Through Inhibiting miR-16. Frontiers in Bioengineering and Biotechnology. 10. 838842–838842. 4 indexed citations
10.
Dai, Ting, Jiayi Ma, Su Ni, et al.. (2022). Attapulgite-doped electrospun PCL scaffolds for enhanced bone regeneration in rat cranium defects. Biomaterials Advances. 133. 112656–112656. 21 indexed citations
11.
Xu, Chao, Su Ni, Nanwei Xu, et al.. (2022). Theaflavin‐3,3′‐Digallate Inhibits Erastin‐Induced Chondrocytes Ferroptosis via the Nrf2/GPX4 Signaling Pathway in Osteoarthritis. Oxidative Medicine and Cellular Longevity. 2022(1). 3531995–3531995. 39 indexed citations
12.
Xu, Chao, Su Ni, Chao Zhuang, et al.. (2021). Polysaccharide from Angelica sinensis attenuates SNP-induced apoptosis in osteoarthritis chondrocytes by inducing autophagy via the ERK1/2 pathway. Arthritis Research & Therapy. 23(1). 47–47. 29 indexed citations
13.
Ni, Su, Dong Li, Hui Wei, Kaisong Miao, & Chao Zhuang. (2021). PPARγ Attenuates Interleukin‐1β‐Induced Cell Apoptosis by Inhibiting NOX2/ROS/p38MAPK Activation in Osteoarthritis Chondrocytes. Oxidative Medicine and Cellular Longevity. 2021(1). 5551338–5551338. 24 indexed citations
14.
Xu, Chao, Tao Jiang, Su Ni, et al.. (2020). FSTL1 promotes nitric oxide-induced chondrocyte apoptosis via activating the SAPK/JNK/caspase3 signaling pathway. Gene. 732. 144339–144339. 12 indexed citations
15.
Ni, Su, et al.. (2020). MgCl2 promotes mouse mesenchymal stem cell osteogenic differentiation by activating the p38/Osx/Runx2 signaling pathway. Molecular Medicine Reports. 22(5). 3904–3910. 19 indexed citations
16.
Ni, Su, Chenkai Li, Nanwei Xu, et al.. (2018). Follistatin‐like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK/STAT3 and NF‐κB pathways. Journal of Cellular Physiology. 234(1). 454–463. 61 indexed citations
17.
Li, Dong, Su Ni, Kaisong Miao, & Chao Zhuang. (2018). PI3K/Akt and caspase pathways mediate oxidative stress-induced chondrocyte apoptosis. Cell Stress and Chaperones. 24(1). 195–202. 80 indexed citations
18.
Miao, Kaisong, Su Ni, Xianju Zhou, et al.. (2015). Hidden blood loss and its influential factors after total hip arthroplasty. Journal of Orthopaedic Surgery and Research. 10(1). 36–36. 73 indexed citations
19.
Ni, Su, Kaisong Miao, Xianju Zhou, et al.. (2015). The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-κB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation. Arthritis Research & Therapy. 17(1). 91–91. 54 indexed citations
20.
Chen, Jiekai, Jing Liu, Jiaqi Yang, et al.. (2010). BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Research. 21(1). 205–212. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhanwang Xu Breakdown of academic impact, for papers by Xiangyu Chu Breakdown of academic impact, for papers by Yongjian Zhao Breakdown of academic impact, for papers by Hongli Jiao Breakdown of academic impact, for papers by Wenxiang Cheng Breakdown of academic impact, for papers by Deming Xiao Breakdown of academic impact, for papers by Huaqiang Tao Breakdown of academic impact, for papers by Liaojun Sun Breakdown of academic impact, for papers by Yiming Zhong
Rankless by CCL
2026